<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>JCAD &#187; Actinic Keratosis</title>
	<atom:link href="http://www.jcadonline.com/category/areas-of-interest/actinic-keratosis/feed/" rel="self" type="application/rss+xml" />
	<link>http://www.jcadonline.com</link>
	<description>The Journal of Clinical and Aesthetic Dermatology (JCAD)</description>
	<lastBuildDate>Thu, 19 Jan 2012 16:38:25 +0000</lastBuildDate>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.3.1</generator>
		<item>
		<title>The Impact of the Current United States Guidelines on the Management of Actinic Keratosis: Is It Time for an Update?</title>
		<link>http://www.jcadonline.com/the-impact-of-the-current-united-states-guidelines-on-the-management-of-actinic-keratosis-is-it-time-for-an-update/</link>
		<comments>http://www.jcadonline.com/the-impact-of-the-current-united-states-guidelines-on-the-management-of-actinic-keratosis-is-it-time-for-an-update/#comments</comments>
		<pubDate>Fri, 05 Nov 2010 16:42:14 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[11-2010 (November 2010)]]></category>
		<category><![CDATA[Actinic Keratoses]]></category>
		<category><![CDATA[Actinic Keratosis]]></category>
		<category><![CDATA[Literature Review]]></category>
		<category><![CDATA["actinic keratoses: sequelae and treatments"]]></category>
		<category><![CDATA["prospective demographic study of cosmetic surgery patients"]]></category>
		<category><![CDATA["the impact of the current united states guidelines"]]></category>
		<category><![CDATA[95 guidelines for dermatology]]></category>
		<category><![CDATA[a supplement to cutis solaraze gel]]></category>
		<category><![CDATA[aad guideliens for treating actinic kertatosis]]></category>
		<category><![CDATA[aad treatment guidelines for actinic keratosis]]></category>
		<category><![CDATA[actinic keatosis clinical development]]></category>
		<category><![CDATA[actinic keratoses guidelines]]></category>
		<category><![CDATA[actinic keratosis 5-fu and tretinoin guideline]]></category>
		<category><![CDATA[actinic keratosis and veterans affairs and actinic keratosis]]></category>
		<category><![CDATA[actinic keratosis clinical guidelines]]></category>
		<category><![CDATA[actinic keratosis cryosurgery plus topical medication]]></category>
		<category><![CDATA[actinic keratosis epidemiology]]></category>
		<category><![CDATA[actinic keratosis european experts]]></category>
		<category><![CDATA[actinic keratosis european guidelines]]></category>
		<category><![CDATA[actinic keratosis follow up visit time]]></category>
		<category><![CDATA[actinic keratosis guideline]]></category>
		<category><![CDATA[actinic keratosis guidelines]]></category>
		<category><![CDATA[actinic keratosis images]]></category>
		<category><![CDATA[actinic keratosis management guidelines]]></category>
		<category><![CDATA[actinic keratosis patient feedback]]></category>
		<category><![CDATA[actinic keratosis treatment algorithm]]></category>
		<category><![CDATA[actinic keratosis treatment guidelines]]></category>
		<category><![CDATA[actinic keratosis treatment guidelines usa american academy dermatology "treatment guidelines"]]></category>
		<category><![CDATA[ak is the second most common diagnosis made by dermatologists]]></category>
		<category><![CDATA[ak treatment guidelines bad]]></category>
		<category><![CDATA[al balkiewicz]]></category>
		<category><![CDATA[ala-]]></category>
		<category><![CDATA[american academy guideline discussions actinic keratosis]]></category>
		<category><![CDATA[australian actinic keratoses guidelines 2008]]></category>
		<category><![CDATA[bad gidelines on actinic keratoses]]></category>
		<category><![CDATA[cache:-sbqqz39ltwj:www.jcadonline.com/a-review-of-the-safety-and-efficacy-of-benzoyl-peroxide-5-3-emollient-foam-in-the-management-of-truncal-acne-vulgaris/ benzoyl micronized]]></category>
		<category><![CDATA[cache:-sbqqz39ltwj:www.jcadonline.com/a-review-of-the-safety-and-efficacy-of-benzoyl-peroxide-5-3-emollient-foam-in-the-management-of-truncal-acne-vulgaris/ meta analysis comparing benzoyl 5% microniz]]></category>
		<category><![CDATA[cellupulse]]></category>
		<category><![CDATA[clinical guidelines actinic keratosis veterans administration]]></category>
		<category><![CDATA[clinical steps to diagnosing actinic keratosis]]></category>
		<category><![CDATA[compare cryotherapy photodynamic keratosis]]></category>
		<category><![CDATA[creams with either tretinoin, adapalene, fluorouracil, diclofenac, or imiquimod]]></category>
		<category><![CDATA[cryotherapy treatment times for actinic keratosis]]></category>
		<category><![CDATA[death rate with actinic keratosis]]></category>
		<category><![CDATA[dermatologists recommendation of topical 5 fu]]></category>
		<category><![CDATA[dermatologists recommendations for treating actinic keratosis]]></category>
		<category><![CDATA[dermatology guidelines united states actinic keratosis]]></category>
		<category><![CDATA[development of a treatment algorithm for actinic keratoses: a european consensus]]></category>
		<category><![CDATA[diclofenac sodium cream 3% gal/recommendations]]></category>
		<category><![CDATA[does treated actinic keratosis with flouracil cream take about 4 weeks to clear up]]></category>
		<category><![CDATA[epidemiology "actinic keratosis"]]></category>
		<category><![CDATA[epidemiology of actinic keratosis us]]></category>
		<category><![CDATA[eu guidelines ak stockfleth]]></category>
		<category><![CDATA[european guideline actinic keratosis]]></category>
		<category><![CDATA[european guidelined for actinic keratosis]]></category>
		<category><![CDATA[european guidelines for the management of actinic keratoses]]></category>
		<category><![CDATA[european guidelines management actinic keratoses 2010]]></category>
		<category><![CDATA[evidence based actinic keratosis]]></category>
		<category><![CDATA[evidence based guildlines for treatment actinic kertosis]]></category>
		<category><![CDATA[evidence based medicine for treatment of actinic keratosis]]></category>
		<category><![CDATA[failure rate of zyclara for actinic keratosis treatment]]></category>
		<category><![CDATA[feldman sr actinic keratosis cutis]]></category>
		<category><![CDATA[field based approach treating actinic keratosis]]></category>
		<category><![CDATA[fluorouracil cream "alternative dosing" actinic]]></category>
		<category><![CDATA[fluorouracil cream 5% price history]]></category>
		<category><![CDATA[fluorouracil cream pulse treatment]]></category>
		<category><![CDATA[george martin md photodynamic therapy maui hawaii]]></category>
		<category><![CDATA[george martin md, jcad]]></category>
		<category><![CDATA[guidances for actinic keratosis]]></category>
		<category><![CDATA[guideline actinic keratosis]]></category>
		<category><![CDATA[guidelines]]></category>
		<category><![CDATA[guidelines actinic keratosis]]></category>
		<category><![CDATA[guidelines ak dermatology]]></category>
		<category><![CDATA[guidelines for follow up actinic keratoses]]></category>
		<category><![CDATA[guidelines for the management of actinic keratoses]]></category>
		<category><![CDATA[guidelines of care for actinic keratoses]]></category>
		<category><![CDATA[guidelines of care for actinic keratosis. committee on guidelines of care]]></category>
		<category><![CDATA[imiquimod shaffelburg]]></category>
		<category><![CDATA[jorizzo dusa]]></category>
		<category><![CDATA[keratosis clinical guidelines]]></category>
		<category><![CDATA[keratosis cryogenic versus flouracil]]></category>
		<category><![CDATA[keratosis guideline]]></category>
		<category><![CDATA[keratosis veterans admin rating]]></category>
		<category><![CDATA[key opinion leader actinic keratoses]]></category>
		<category><![CDATA[krawtchenko imiquimod abstract 3.75]]></category>
		<category><![CDATA[martin]]></category>
		<category><![CDATA[mastrolonardo solaraze]]></category>
		<category><![CDATA[maui derm 2011 solaraze]]></category>
		<category><![CDATA[mcintyre et al ak treatment]]></category>
		<category><![CDATA[medicare expenditure actinic keratosis 2010]]></category>
		<category><![CDATA[normal-blood-chemistry-panel]]></category>
		<category><![CDATA[number of physician visits for actinic keratosis]]></category>
		<category><![CDATA[omega fats]]></category>
		<category><![CDATA[pdf journal of clinical and aesthetic dermatology 2010 3 11 20 martin]]></category>
		<category><![CDATA[pharmaceutical companies actinic keratosis treatment options]]></category>
		<category><![CDATA[pharmacoeconomics diclofenac imiquimod]]></category>
		<category><![CDATA[Photodynamic Therapy]]></category>
		<category><![CDATA[pneumococcal-vaccine-13-side-effects]]></category>
		<category><![CDATA[pulse dosing carac cream]]></category>
		<category><![CDATA[quaedvlieg pj, tirsi e, thissen mr, krekels ga. actinic keratosis: how to differentiate the good from the bad ones? eur j dermatol. 2006;16:335–339]]></category>
		<category><![CDATA[regulatory guidelines for dermatology studies-eu]]></category>
		<category><![CDATA[review "actinic keratosis" "evidence base"]]></category>
		<category><![CDATA[skin academy treatment algorithm]]></category>
		<category><![CDATA[smith sr, piacquadio dj. bilateral comparison of the efficacy and tolerability of diclofenac sodium 3% gell]]></category>
		<category><![CDATA[solaraze gel]]></category>
		<category><![CDATA[stockfleth, e., et al., development of a treatment algorithm for actinic keratoses a european consensus 2008]]></category>
		<category><![CDATA[the impact of the current united states guidelines on the management of actinic keratosis]]></category>
		<category><![CDATA[the impact of the current united states guidelines on the management of actinic keratosis: is it time for an update?]]></category>
		<category><![CDATA[the use of photodynamic therapy in the treatment of skin cancer]]></category>
		<category><![CDATA[topical 0.5% fluorouracil (fu) cream for the treatment of actinic keratoses (ak): an open-label 18-month safety study stough]]></category>
		<category><![CDATA[topical actinic keratosis treatment europe]]></category>
		<category><![CDATA[topical diclofenac 3% gel plus cryotherapy for treatment of multiple and recurrent actinic keratoses. clin exp dermatol. 2009]]></category>
		<category><![CDATA[treatment adherence actinic keratosis us]]></category>
		<category><![CDATA[treatment of actinic keratoses with sequential combination of 5-fluorouracil]]></category>
		<category><![CDATA[tretinonin and 5-fu]]></category>
		<category><![CDATA[up-date cure rate for actinic keratosis]]></category>
		<category><![CDATA[us treatment actinic keratoses review]]></category>
		<category><![CDATA[usa guidelines actinic keratosis cryotherapy]]></category>
		<category><![CDATA[va claim for actinic keratoses]]></category>
		<category><![CDATA[veteran administration/dry skin]]></category>
		<category><![CDATA[veterans actinic keratosis]]></category>
		<category><![CDATA[veterans actinic keratosis pdt]]></category>
		<category><![CDATA[veterans administration guidelines]]></category>
		<category><![CDATA[veterans administration schedule ratings for keratitis]]></category>
		<category><![CDATA[veterans administration treatment for actinic keratoses]]></category>
		<category><![CDATA[veterans boston benefits 3/14/11]]></category>
		<category><![CDATA[vetrian adminstration photodynamic therapy]]></category>
		<category><![CDATA[vipeel]]></category>
		<category><![CDATA[witheiler et al 5 fu]]></category>
		<category><![CDATA[zeichner]]></category>
		<category><![CDATA[zeichnetr]]></category>
		<category><![CDATA[zyclara]]></category>

		<guid isPermaLink="false">http://www.jcadonline.com/?p=2976</guid>
		<description><![CDATA[George Martin, MD Dermatology and Laser Center of Maui, Kihei, Hawaii Disclosure: Dr. Martin is a medical consultant for DUSA Pharmaceuticals, Inc., and has served on the scientific advisory boards for DUSA Pharmaceuticals, Inc., Galderma, Sanofi-Aventis, Abbott Laboratories, LEO Pharma, and Medicis Pharmaceutical Corporation. He is also a speaker for DUSA Pharmaceuticals, Inc., Medicis Pharmaceutical [...]]]></description>
		<wfw:commentRss>http://www.jcadonline.com/the-impact-of-the-current-united-states-guidelines-on-the-management-of-actinic-keratosis-is-it-time-for-an-update/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>

